Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
dextroamphetamine sulfate
|
| gptkbp:alternativeName |
gptkb:dextroamphetamine
|
| gptkbp:ATCCode |
N06BA02
|
| gptkbp:chemicalClass |
amphetamine
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_II_(US)
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:discontinued |
yes
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dextrostat
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:UCB_Pharma
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
anxiety
loss of appetite increased heart rate insomnia dry mouth |
| gptkbp:usedFor |
gptkb:attention_deficit_hyperactivity_disorder
narcolepsy |
| gptkbp:bfsParent |
gptkb:dextroamphetamine
|
| gptkbp:bfsLayer |
7
|